BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Fabbrocini G, Panariello L, De Vita V, Vincenzi C, Lauro C, Nappo D, Ayala F, Tosti A. Quality of life in alopecia areata: a disease-specific questionnaire. J Eur Acad Dermatol Venereol. 2013;27:e276-e281. [PMID: 22759244 DOI: 10.1111/j.1468-3083.2012.04629.x] [Cited by in Crossref: 29] [Cited by in F6Publishing: 25] [Article Influence: 3.2] [Reference Citation Analysis]
Number Citing Articles
1 Tan H, Lan XM, Yu NL, Yang XC. Reliability and validity assessment of the revised Symptom Checklist 90 for alopecia areata patients in China. J Dermatol 2015;42:975-80. [PMID: 26072969 DOI: 10.1111/1346-8138.12976] [Cited by in Crossref: 21] [Cited by in F6Publishing: 13] [Article Influence: 3.5] [Reference Citation Analysis]
2 Dlova NC, Fabbrocini G, Lauro C, Spano M, Tosti A, Hift RH. Quality of life in South African Black women with alopecia: a pilot study. Int J Dermatol 2016;55:875-81. [DOI: 10.1111/ijd.13042] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 1.7] [Reference Citation Analysis]
3 Russo P, Fino E, Mancini C, Mazzetti M, Starace M, Piraccini B. HrQoL in hair loss‐affected patients with alopecia areata, androgenetic alopecia and telogen effluvium: the role of personality traits and psychosocial anxiety. J Eur Acad Dermatol Venereol 2018;33:608-11. [DOI: 10.1111/jdv.15327] [Cited by in Crossref: 17] [Cited by in F6Publishing: 10] [Article Influence: 5.7] [Reference Citation Analysis]
4 Rencz F, Gulácsi L, Péntek M, Wikonkál N, Baji P, Brodszky V. Alopecia areata and health-related quality of life: a systematic review and meta-analysis. Br J Dermatol 2016;175:561-71. [PMID: 26914830 DOI: 10.1111/bjd.14497] [Cited by in Crossref: 63] [Cited by in F6Publishing: 44] [Article Influence: 12.6] [Reference Citation Analysis]
5 Saceda-Corralo D, Grimalt R, Fernández-Crehuet P, Clemente A, Bernárdez C, García-Hernandez MJ, Arias-Santiago S, Rodrigues-Barata AR, Rodríguez-Pichardo A, García-Lora E, Jaén P, Camacho FM, Vañó-Galván S. Beard alopecia areata: a multicentre review of 55 patients. J Eur Acad Dermatol Venereol 2017;31:187-92. [PMID: 27503140 DOI: 10.1111/jdv.13896] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
6 Chernyshov PV, Tomas-Aragones L, Finlay AY, Manolache L, Marron SE, Sampogna F, Spillekom-van Koulil S, Pustisek N, Suru A, Evers AWM, Salavastru C, Svensson A, Abeni D, Blome C, Poot F, Jemec GBE, Linder D, Augustin M, Bewley A, Salek SS, Szepietowski JC. Quality of life measurement in alopecia areata. Position statement of the European Academy of Dermatology and Venereology Task Force on Quality of Life and Patient Oriented Outcomes. J Eur Acad Dermatol Venereol 2021;35:1614-21. [PMID: 34107093 DOI: 10.1111/jdv.17370] [Reference Citation Analysis]
7 Toussi A, Barton VR, Le ST, Agbai ON, Kiuru M. Psychosocial and psychiatric comorbidities and health-related quality of life in alopecia areata: A systematic review. J Am Acad Dermatol 2021;85:162-75. [PMID: 32561373 DOI: 10.1016/j.jaad.2020.06.047] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 5.0] [Reference Citation Analysis]
8 Gonul M, Cemil BC, Ayvaz HH, Cankurtaran E, Ergin C, Gurel MS. Comparison of quality of life in patients with androgenetic alopecia and alopecia areata. An Bras Dermatol 2018;93:651-8. [PMID: 30156613 DOI: 10.1590/abd1806-4841.20186131] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
9 Titeca G, Goudetsidis L, Francq B, Sampogna F, Gieler U, Tomas-Aragones L, Lien L, Jemec GBE, Misery L, Szabo C, Linder D, Evers AWM, Halvorsen JA, Balieva F, Szepietowski J, Romanov D, Marron SE, Altunay IK, Finlay AY, Salek SS, Kupfer J, Dalgard FJ, Poot F. 'The psychosocial burden of alopecia areata and androgenetica': a cross-sectional multicentre study among dermatological out-patients in 13 European countries. J Eur Acad Dermatol Venereol 2020;34:406-11. [PMID: 31465592 DOI: 10.1111/jdv.15927] [Cited by in Crossref: 15] [Cited by in F6Publishing: 4] [Article Influence: 7.5] [Reference Citation Analysis]
10 Napolitano M, Di Guida A, Nocerino M, Fabbrocini G, Patruno C. The emerging role of dupilumab in dermatological indications. Expert Opin Biol Ther 2021;:1-11. [PMID: 33769900 DOI: 10.1080/14712598.2021.1907341] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Anyanwu C, Langenhan J, Werth VP. Measurement of disease severity in cutaneous autoimmune diseases. F1000Prime Rep 2013;5:19. [PMID: 23755366 DOI: 10.12703/P5-19] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
12 Ahn H, Lee SY, Jung WJ, Lee KH. Alopecia treatment using minimally manipulated human umbilical cord-derived mesenchymal stem cells: Three case reports and review of literature. World J Clin Cases 2021;9:3741-51. [PMID: 34046478 DOI: 10.12998/wjcc.v9.i15.3741] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
13 Yu N, Hu T, Yang H, Zhang L, Song Q, Xiang F, Yang X, Li Y. Twist1 Contributes to the Maintenance of Some Biological Properties of Dermal Papilla Cells in vitro by Forming a Complex With Tcf4 and β-Catenin. Front Cell Dev Biol 2020;8:824. [PMID: 32974352 DOI: 10.3389/fcell.2020.00824] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Gallo R, Chiorri C, Gasparini G, Signori A, Burroni A, Parodi A. Can mindfulness-based interventions improve the quality of life of patients with moderate/severe alopecia areata? A prospective pilot study. J Am Acad Dermatol 2017;76:757-9. [PMID: 28325394 DOI: 10.1016/j.jaad.2016.10.012] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
15 Aldhouse NVJ, Kitchen H, Knight S, Macey J, Nunes FP, Dutronc Y, Mesinkovska N, Ko JM, King BA, Wyrwich KW. "'You lose your hair, what's the big deal?' I was so embarrassed, I was so self-conscious, I was so depressed:" a qualitative interview study to understand the psychosocial burden of alopecia areata. J Patient Rep Outcomes 2020;4:76. [PMID: 32914253 DOI: 10.1186/s41687-020-00240-7] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 7.0] [Reference Citation Analysis]
16 Davis DS, Callender VD. Review of quality of life studies in women with alopecia. Int J Womens Dermatol 2018;4:18-22. [PMID: 29872671 DOI: 10.1016/j.ijwd.2017.11.007] [Cited by in Crossref: 27] [Cited by in F6Publishing: 17] [Article Influence: 9.0] [Reference Citation Analysis]
17 Abedini R, Hallaji Z, Lajevardi V, Nasimi M, Karimi Khaledi M, Tohidinik HR. Quality of life in mild and severe alopecia areata patients. Int J Womens Dermatol 2018;4:91-4. [PMID: 29872683 DOI: 10.1016/j.ijwd.2017.07.001] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
18 Liu LY, Craiglow BG, King BA. Successful treatment of moderate-to-severe alopecia areata improves health-related quality of life. J Am Acad Dermatol 2018;78:597-599.e2. [PMID: 29128459 DOI: 10.1016/j.jaad.2017.10.046] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
19 Yu N, Tan H, Song Z, Yang X. Illness perception in patients with androgenetic alopecia and alopecia areata in China. Journal of Psychosomatic Research 2016;86:1-6. [DOI: 10.1016/j.jpsychores.2016.04.005] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 2.2] [Reference Citation Analysis]
20 Saceda-Corralo D, Pindado-Ortega C, Moreno-Arrones ÓM, Fernández-González P, Rodrigues-Barata AR, Jaén-Olasolo P, Vañó-Galván S. Health-Related Quality of Life in Patients With Frontal Fibrosing Alopecia. JAMA Dermatol 2018;154:479-80. [PMID: 29516093 DOI: 10.1001/jamadermatol.2017.6330] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
21 Doghaim NN, El‐tatawy RA, Neinaa YME, Abd El‐samd MM. Study of the efficacy of carboxytherapy in alopecia. J Cosmet Dermatol 2018;17:1275-85. [DOI: 10.1111/jocd.12501] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 2.7] [Reference Citation Analysis]
22 Dainichi T, Kabashima K. Alopecia areata: What's new in epidemiology, pathogenesis, diagnosis, and therapeutic options? J Dermatol Sci 2017;86:3-12. [PMID: 27765435 DOI: 10.1016/j.jdermsci.2016.10.004] [Cited by in Crossref: 27] [Cited by in F6Publishing: 19] [Article Influence: 5.4] [Reference Citation Analysis]
23 Mendoza TR, Osei J, Duvic M. The Utility and Validity of the Alopecia Areata Symptom Impact Scale in Measuring Disease-Related Symptoms and their Effect on Functioning. Journal of Investigative Dermatology Symposium Proceedings 2018;19:S41-6. [DOI: 10.1016/j.jisp.2017.10.009] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
24 Thadanipon K, Suchonwanit P. Measuring Patient Quality of Life Following Treatment for Alopecia. Patient Prefer Adherence 2021;15:1601-10. [PMID: 34295154 DOI: 10.2147/PPA.S282399] [Reference Citation Analysis]
25 Kassim J, Shipman A, Szczecinska W, Siah T, Lam M, Chalmers J, Macbeth A. How effective is intralesional injection of triamcinolone acetonide compared with topical treatments in inducing and maintaining hair growth in patients with alopecia areata? A Critically Appraised Topic. Br J Dermatol 2014;170:766-71. [DOI: 10.1111/bjd.12863] [Cited by in Crossref: 17] [Cited by in F6Publishing: 9] [Article Influence: 2.4] [Reference Citation Analysis]